ALK and neurofibromatosis type 1: Third, midkine, a ligand that activates mammalian ALK [95], is produced by NF1−/− Schwann cells, present at elevated levels in NF1 patient skin and serum, and acts as a mitogen for NF1 tumor cell lines [96]–[98].